Showing results (551-560 of 576) with videos related to

Sort By:
Pageof 58
Molecules (Basel, Switzerland)|August 5, 2014
Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cellsXu-An Wang, Shan-Shan Xiang, Huai-Feng Li, et al.
Molecular Metabolism|November 26, 2018
The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormonesOlga Rudenko, Jin Shang, Alexander Munk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
Molecules (Basel, Switzerland)|August 29, 2014
Schisandrin B induces apoptosis and cell cycle arrest of gallbladder cancer cellsShan-Shan Xiang, Xu-An Wang, Huai-Feng Li, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 InhibitionWeiguo Liu, Pengcheng P Shao, Gui-Bai Liang, et al.
Cell Death and Differentiation|January 7, 2017
MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathwayYi-Jun Shu, Run-Fa Bao, Lin Jiang, et al.
Molecules (Basel, Switzerland)|December 11, 2025
RETRACTED: Xiang et al. Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells. Molecules 2014, 19, 13235-13250Shan-Shan Xiang, Xu-An Wang, Huai-Feng Li, et al.
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2017
PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal CancerJian-Ming Xu, Yan Wang, You-Liang Wang, et al.
The Journal of Infectious Diseases|May 6, 2025
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, et al.
Pageof 58